This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Vifor (International) AG. The BPA utilizes the Pharmaceuticals and Drugs GSA Schedule to provide Mircera, an anemia treatment medication, to the VA. With a potential value of $23.8 million over a base year and four option years, the BPA aims to procure Mircera to treat veterans suffering from anemia.
The single award BPA has a last date to order of June 2, 2021 and was awarded on April 30, 2020. No set-aside provisions were used in the award. As the VA's goal is to provide quality healthcare to those who have served, this BPA will help the VA treat anemia experienced by veterans by facilitating the procurement of Mircera from the prime contractor, Vifor (International) AG, over the five year period of performance. Use of the Pharmaceuticals and Drugs GSA schedule streamlines the acquisition process for this critical medication needed by veterans served by the VA healthcare system.
Generated 1/4/24, 6:51 PM